Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD
danny2024-01-31T15:12:09-05:00Award will advance the Self-Assembling Vaccine Platform for rapid [...]
Lucius Partners Portfolio Company Voltron Therapeutics, Inc Adds Manufacturing Expert to Scientific Advisory Board
danny2024-01-31T15:09:40-05:00Globally recognized manufacturing and product supply expert Tibor [...]
Lucius Partners Portfolio Company Voltron Therapeutics Announces Robust Immunogenicity Data: Key Prostate Cancer Target
danny2023-09-06T15:53:23-04:00Self Assembling Vaccine targets Prostate Stem Cell Antigen [...]
Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD
danny2023-08-25T14:19:08-04:00Voltron Therapeutics, a Lucius Partners Company, with the [...]
Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling Vaccine in Fight Against COVID-19
danny2020-07-09T16:20:15-04:00Voltron Therapeutics, Inc. Initiates Animal Testing of Self-Assembling [...]
Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore Strategic Alternatives for its HaloVax™ Subsidiary
danny2020-07-09T16:08:48-04:00Voltron Therapeutics Retains Buenaventura Advisors, LLC to Explore [...]
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer VaccineVoltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement with The Vaccine & Immunotherapy Center at the Massachusetts General Hospital to Advance the Development of a Personalized Cancer Vaccine
danny2020-06-11T12:42:24-04:00Voltron Therapeutics, Inc. Enters into Sponsored Research Agreement [...]
Voltron Therapeutics Publishes Letter to Shareholders
danny2020-05-19T17:37:41-04:00Voltron Therapeutics Publishes Letter to Shareholders
Dr. Poznansky is interviewed on Bloomberg Radio
danny2020-04-30T20:33:44-04:00Listen to Dr. Poznanski's interview on Bloomberg Radio and his thoughts on operation "Warp Speed"
Voltron Therapeutics, Inc. Announces Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 VaccineVoltron Therapeutics, Inc. Announces Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine
Voltron Therapeutics, Inc. Announces Selection of the First of Two Sets of Virus Targeting Peptides for Animal Testing in the Development of a COVID-19 Vaccine
danny2020-04-24T14:49:21-04:00Voltron Therapeutics, Inc. Announces Selection of the First [...]